abacavir/lamivudine sandoz
sandoz d.d. - abakaviras/lamivudinas - plėvele dengtos tabletės - 600 mg/300 mg - lamivudine and abacavir
macmiror complex
mra, uab - nifuratelis/nistatinas - makšties kremas - 500 mg/200000 tv; 100 mg/40000 tv/g - other antiinfectives and antiseptics
nexium
grünenthal gmbh - ezomeprazolas - skrandyje neirios tabletės - 40 mg; 20 mg - esomeprazole
picoprep
ferring gmbh - natrio pikosulfatas/magnio oksidas, lengvasis/citrinų rūgštis - milteliai geriamajam tirpalui - 10 mg/3,5 g/12 g - sodium picosulfate, combinations
anesia
baxter holding b.v. - propofolis - injekcinė ar infuzinė emulsija - 10 mg/ml; 20 mg/ml - propofol
sterofundin iso
b.braun melsungen ag - natrio chloridas/kalio chloridas/magnio chloridas heksahidratas/kalcio chloridas dihidratas/natrio acetatas trihidratas/l-obuolių rūgštis - infuzinis tirpalas - 6,8 g/0,3 g/0,2 g/0,37 g/3,27 g/0,67 g/1000 ml - electrolytes
vinorelbin ebewe
sandoz d.d. - vinorelbinas - koncentratas infuziniam tirpalui - 10 mg/ml - vinorelbine
abacavir/lamivudine zentiva
zentiva k.s. - abakaviras/lamivudinas - plėvele dengtos tabletės - 600 mg/300 mg - lamivudine and abacavir
abacavir/lamivudine auxilia
auxilia pharma oÜ - abakaviras/lamivudinas - plėvele dengtos tabletės - 600 mg/300 mg - lamivudine and abacavir
abecma
bristol-myers squibb pharma eeig - idecabtagene vicleucel - multiple myeloma; neoplasms; cancer; neoplasms, plasma cell; hemostatic disorders; vascular diseases; cardiovascular diseases; paraproteinemias; blood protein disorders; hematologic diseases; hemic and lymphatic diseases; hemorrhagic disorders; infectious mononucleosis; lymphoproliferative disorders; immunoproliferative disorders; immune system diseases - antinavikiniai vaistai - abecma is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti cd38 antibody and have demonstrated disease progression on the last therapy.